3 weeks after the first human trials of the Marburg vaccine show "promising results", the WHO makes an official announcement regarding concerns of a Marburg outbreak in Africa
https://twitter.com/i/status/1626825846156828675
what a relief we have the vaccine to fall back on AND they are already telling us development can be speeded. It is being developed at USA's National Institutes of Health NIH where Faucci is the Director
#Marburg
niaid.nih.gov/news-events/ma….
#Marburg
niaid.nih.gov/news-events/ma….
the investigational vaccine appeared to induce strong, long-lasting immunity to the MARV glycoprotein: 95% of participants in the trial exhibited a robust antibody response after vaccination, and 70% maintained that response for more than 48 weeks.
Plans are in place to conduct further trials of the cAd3-Marburg vaccine in Ghana, Kenya, Uganda, and the United States. If additional data supports the promising results seen in the Phase 1 trial, the cAd3-Marburg virus vaccine could someday be used in emergency responses.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
